Lanluma® V Injectable Poly-L-Lactic Acid for Clinics

This injectable poly-L-lactic acid preparation supports subdermal volume restoration in trained hands. Clinics use it for collagen stimulation in facial and body workflows. Available through US distribution for verified accounts.

Lanluma® V is supplied as a powder for reconstitution with sterile water prior to injection. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors. This formulation fits clinic protocols that prioritize gradual, natural-looking contour improvement over immediate gel filling.

What Lanluma Is and How It Works

This class is a biostimulatory implant composed of poly-L-lactic acid (PLLA) microparticles intended for subdermal placement. After proper preparation, particles act as a temporary scaffold that can stimulate fibroblasts and support new collagen formation over time. Lanluma V injection is used by licensed professionals familiar with PLLA handling and subdermal injection techniques. Outcomes appear progressively as neocollagenesis occurs, aligning with staged treatment planning.

Unlike hyaluronic acid gels, this product does not provide an immediate volumetric fill. It supports gradual tissue remodeling that can persist beyond the treatment series, with durations that may extend up to two years depending on individual factors and technique. Many clinics integrate this agent where a sustained collagen response is preferred, then reassess intervals for maintenance as indicated by patient presentation. For background on class selection, see Sculptra Vs Juvederm.

Professional Applications

Common professional uses include large-area volumization and contour refinement where subtle, steady change is desired. Typical areas can include cheeks, temples, jawline, and body zones that benefit from structural support such as the buttocks. Many trade searches refer to this product as Lanluma V filler; however, it is a PLLA biostimulator rather than a hyaluronic acid filler.

Clinics often incorporate the preparation into staged aesthetic plans alongside other modalities when appropriate. It can complement HA gels for focal shaping or thread lifts for soft tissue repositioning, sequenced according to clinical judgment. For body-focused planning and intake workflows, explore Body Contouring and Body Sculpting categories.

Key Features

• PLLA biostimulator: supports collagen formation after subdermal placement.
• Gradual change: progressive, natural-looking contour improvement over weeks.
• Long horizon: effects can persist up to two years, subject to technique and biology.
• Reconstitution step: powder prepared with sterile water prior to use.
• Subdermal delivery: intended for injection by trained, licensed professionals.
• Scalable use: appropriate for facial contouring and non-surgical body volumization.
• Workflow friendly: staged sessions can align with assessment and follow-up schedules.
• Not an HA gel: distinct handling and mechanism versus hyaluronic acid fillers.
• Professional-only product: requires appropriate training in PLLA preparation and injection.
• Reference-ready: class background available in PLLA Overview.

Benefits in Practice

This product supports predictable scheduling with an induction-based mechanism that unfolds over several weeks. Clinics can pace sessions to monitor tissue response and adjust plans. The approach suits patients who prefer steady, natural-looking changes that blend with surrounding tissues.

It integrates smoothly with multimodal protocols. Teams may pair the agent with hyaluronic acid for focal refinement or thread-based repositioning in the same care pathway when clinically appropriate. For modality planning and staff education, see Dermal Fillers and the technique primer PDO Threads.

• Staged scheduling: supports assessment-driven intervals and maintenance planning.
• Face and body reach: useful for larger areas where subtle lift is preferred.
• Inventory efficiency: powder format simplifies storage prior to reconstitution.
• Protocol synergy: aligns with HA gels and threads in comprehensive programs.

Composition & Ingredients

The active component is poly-L-lactic acid (PLLA), a biodegradable, biocompatible polymer used as a tissue scaffold for collagen support. The powder is reconstituted with sterile water per manufacturer guidance before subdermal administration. As a reminder, Lanluma V poly-L-lactic acid is a biostimulator, not a hyaluronic acid filler.

• Active: Poly-L-lactic acid (PLLA).
• Content: 630 mg per vial.
• Form: Powder for suspension following reconstitution with sterile water.
• Excipients: Refer to the current manufacturer insert for full list.

Packaging & Supply

Each unit is presented as a single-use vial containing the active polymer. Strength is designated at the vial level to aid inventory control and charting. The label and outer carton typically display lot number and expiry for quality documentation.

Clinics should note the specific concentration reference when planning stock. The phrase Lanluma V 630 mg vial reflects the unit content per vial. This is a professional-use item that requires proper reconstitution technique and licensed administration.

Ordering & Logistics

Account verification is required prior to purchase. Sign in to view availability and request volume or contract tiers appropriate for your organization. Our team can assist with documentation and supply planning for multi-site practices or staged programs.

Please place orders through your account portal to ensure accurate clinic details and compliance. If your workflow is building a staged PLLA protocol, you can Order poly-L-lactic acid injection alongside adjunct products in a single shipment. Contact support for lead times and allocation guidance during peak periods.

Comparable Products

Clinics comparing biostimulatory strategies often evaluate alternative stimulators and HA-based options for complementary use. Consider Ultra V Ultracol for class-adjacent stimulation workflows, or an HA range such as Teosyal RHA for focal lift and surface refinement within combination plans.

Pricing & Access

Sign in to your account to view current tiers and request contract pricing aligned with clinic volumes. Quote support is available for larger programs, training events, or multi-site standardization. Pricing is presented to licensed organizations following verification.

Purchases are limited to qualified medical professionals trained in PLLA preparation and injection techniques. For formulary decisions, our team can share product documentation, shelf-life details, and class background upon request.

Availability & Substitutions

Inventory may vary based on manufacturer allocation and regional demand. If a substitution is required for scheduling continuity, confirm suitability with your clinical lead before making changes to a planned protocol. We can suggest category alternatives when appropriate.

For adjacent options and program planning, review Dermal Fillers or body-focused categories including Body Contouring.

Authoritative Sources

• FDA: Dermal Fillers (Soft Tissue Fillers)
• NIH NLM: Poly-L-Lactic Acid (PubChem)
• MedlinePlus: Dermal Fillers Overview

Ready to align supply with your clinic’s schedule? Sign in to secure inventory with temperature-controlled handling when required and tracked US delivery.